Activation of immune signals during organ transplantation

Abstract

The activation of host’s innate and adaptive immune systems can lead to acute and chronic graft rejection, which seriously impacts graft survival. Thus, it is particularly significant to clarify the immune signals, which are critical to the initiation and maintenance of rejection generated after transplantation. The initiation of response to graft is dependent on sensing of danger and stranger molecules. The ischemia and reperfusion of grafts lead to cell stress or death, followed by releasing a variety of damage-associated molecular patterns (DAMPs), which are recognized by pattern recognition receptors (PRRs) of host immune cells to activate intracellular immune signals and induce sterile inflammation. In addition to DAMPs, the graft exposed to ‘non-self’ antigens (stranger molecules) are recognized by the host immune system, stimulating a more intense immune response and further aggravating the graft damage. The polymorphism of MHC genes between different individuals is the key for host or donor immune cells to identify heterologous ‘non-self’ components in allogeneic and xenogeneic organ transplantation. The recognition of ‘non-self’ antigen by immune cells mediates the activation of immune signals between donor and host, resulting in adaptive memory immunity and innate trained immunity to the graft, which poses a challenge to the long-term survival of the graft. This review focuses on innate and adaptive immune cells receptor recognition of damage-associated molecular patterns, alloantigens and xenoantigens, which is described as danger model and stranger model. In this review, we also discuss the innate trained immunity in organ transplantation.

Boosting Sono-immunotherapy of Prostate Carcinoma through Amplifying Domino-Effect of Mitochondrial Oxidative Stress Using Biodegradable Cascade-Targeting Nanocomposites

“…Upon undergoing ICD, dying tumor cells release a cascade of distress-signaling molecules, known as DAMPs. These DAMPs can bind to pattern recognition receptors (PRRs) on the surface of DCs, which will help them to enhance the efficiency of antigen presentation, subsequently activating innate and adaptive immune responses to cause the elimination of tumors . To investigate whether MCTH NCs can effectively initiate ICD and promote the release of DAMPs, we have evaluated the expression of the following markers in vitro : CRT, HSP90, HMGB1, and extracellular adenosine triphosphate (eATP).…”

Extracellular vimentin as a modulator of the immune response and an important player during infectious diseases

“…In certain cancer types, such as glioblastoma, breast, lung, gastric, liver and pancreatic cancer, tumor cells may actively release vimentin into the extracellular space. [34][35][36][37][38][39] This dual role of eVim in both passive and active release underscores its potential impact on various disease processes.…”

Biomaterial-enhanced treg cell immunotherapy: A promising approach for transplant medicine and autoimmune disease treatment

“…In the initial stages following transplantation, both the direct and indirect pathways of antigen presentation come into play, involving APCs, such as DCs, from both the donor and recipient. These processes can contribute to graft rejection [ 215 ]. To prevent the loss of transplanted organs, recipients are required to undergo long-term immunosuppressive therapy.…”